Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development-Reference-Cited by-同舟云学术

Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development

Published:1989-12 Issue:4 Volume:24 Page:548-557
ISSN:0360-4012
Container-title:Journal of Neuroscience Research
language:en
Short-container-title:J. Neurosci. Res.

Author:

Bansal R.,Warrington A. E.,Gard A. L.,Ranscht B.,Pfeiffer S. E.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Reference36 articles.

1. Developmental expression of 2?,3? -cyclic nucleotide 3? -phosphohydrolase in dissociated fetal rat brain cultures and rat brain

2. Regulated Galactolipid Synthesis and Cell Surface Expression in Schwann Cell Line D6P2T

3. Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids.

4. Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid

5. (1989): Oligodendrocyte progenitor development: Reversible inhibition by a monoclonal antibody reacting with galactocerebroside and sulfatide. In (ed): Differentation and Function of Glia. New York: Alan R. Liss, Inc. (in press).

Cited by 408 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schwann cell-secreted PGE2 promotes sensory neuron excitability during development;Cell;2024-08

2. A New Acquaintance of Oligodendrocyte Precursor Cells in the Central Nervous System;Neuroscience Bulletin;2024-07-23

3. Pathogenic myelin-specific antibodies in multiple sclerosis target conformational proteolipid protein 1–anchored membrane domains;Journal of Clinical Investigation;2023-10-02

4. Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin;Cell Reports;2023-05

5. Cell reprogramming for oligodendrocytes: A review of protocols and their applications to disease modeling and cell‐based remyelination therapies;Journal of Neuroscience Research;2023-02-07